25-MULTI-69-PSV-PMC (PSV359-001): A Phase I/II Image-Guided, Alpha-Particle Therapy Study of [203Pb]PSV359 and [212Pb]Pb-PSV359 in Patients with Solid Tumors that are Known to be Fibroblast Activation Protein (FAP)-Positive

Grants and Contracts Details

StatusActive
Effective start/end date12/9/25 → 12/9/27

Funding

  • Perspective Therapeutics Incorporated: $2.00